As Anaptysbio seeks to split off a royalty business, both companies claim the other breached contracts surrounding ...

The pharmaceutical company’s success developing medicines for obesity has swelled its worth to levels associated with tech ...

The FDA will now allow biotechs to ask agency staff for “quick clarifications” via email. Elsewhere, Novartis hiked guidance for two top drugs and a startup nearing “unicorn” status secured a ...

Shares of Contineum Therapeutics dipped by the double-digits late Thursday after investors learned of a clinical setback for ...